From Bio-X to BioSTAR and beyond – the SPARK At Stanford way. Finding a path to developing a treatment for neurodegenerative diseases

Stanford Bio-X Frontiers in Interdisciplinary Biosciences Seminar
DARIA MOCHLY-ROSEN, DEPARTMENT OF CHEMICAL & SYSTEMS BIOLOGY

Dr. Daria Mochly-Rosen founded the SPARK program to provide a cost-effective model to generate proof of concept using industry standards. Since 2006, SPARK has advanced scores of new diagnostics and drugs to the clinic and commercial sectors and educated hundreds of faculty, postdoctoral fellows, and students on the translational process. The majority of SPARK projects address the neglected areas of child and maternal health, global health, and orphan diseases. SPARK is a unique partnership between university and industry experts. SPARK provides access to specialized knowledge and technical expertise regarding drug and diagnostic development, dedicated core laboratory facilities, and sources of funding to support translational efforts.

Dr. Mochly-Rosen's lab is a multi-disciplinary research lab that includes chemists, biochemists, biologists and physician scientists. They develop pharmacological agents and apply them to understand molecular and cellular events under basal and disease conditions using in vitro, in culture and in vivo models.

October 23rd, 2018 at 4:00 PM in Clark Center Seminar Room S361

Don't miss the companion seminar:

Sylvaine Cases, Vice President, Oncology Scientific Innovation, Johnson & Johnson Innovation

"Powering Innovation through academia-industry cross-talk", October 25th, 2018 at 4:00 PM in Clark S360